Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different duloxetine dose comparison in chronic low back pain
IRCT20260627069967N1Phase 3Recruiting
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of duloxetine in chronic low back pain (CLBP), degenerative disc disease (DDD), Bulging Disc and 1 more (3 arms), sponsored by Shahrekord University of Medical Sciences. Primary endpoints: Pain intensity by Visual Analogue Scale and Adverse events. Started Jul 2026; status: recruiting.
02
Drugs
duloxetine
03
Conditions
chronic low back pain (CLBP)degenerative disc disease (DDD)Bulging Discherniated disc
Beyond the preview
Go deeper on IRCT20260627069967N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260627069967N1.